Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Scoliosis is an abnormal curve in the spinal cord. Depending on the severity of the curve and the risk of it deteriorating, scoliosis can be treated with bracing or surgery. There is no cure for scoliosis, but the pain can be alleviated.
The global Scoliosis Treatment market was valued at US$ 2205.1 million in 2023 and is anticipated to reach US$ 2649.1 million by 2030, witnessing a CAGR of 2.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Scoliosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Scoliosis Treatment.
Report Scope
The Scoliosis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Scoliosis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Scoliosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Scoliosis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Scoliosis Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Infantile Idiopathic Scoliosis
1.2.3 Adolescent Idiopathic Scoliosis
1.3 Market by Application
1.3.1 Global Scoliosis Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals & Clinics
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Scoliosis Treatment Market Perspective (2019-2030)
2.2 Scoliosis Treatment Growth Trends by Region
2.2.1 Global Scoliosis Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Scoliosis Treatment Historic Market Size by Region (2019-2024)
2.2.3 Scoliosis Treatment Forecasted Market Size by Region (2025-2030)
2.3 Scoliosis Treatment Market Dynamics
2.3.1 Scoliosis Treatment Industry Trends
2.3.2 Scoliosis Treatment Market Drivers
2.3.3 Scoliosis Treatment Market Challenges
2.3.4 Scoliosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Scoliosis Treatment Players by Revenue
3.1.1 Global Top Scoliosis Treatment Players by Revenue (2019-2024)
3.1.2 Global Scoliosis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Scoliosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Scoliosis Treatment Revenue
3.4 Global Scoliosis Treatment Market Concentration Ratio
3.4.1 Global Scoliosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Scoliosis Treatment Revenue in 2023
3.5 Scoliosis Treatment Key Players Head office and Area Served
3.6 Key Players Scoliosis Treatment Product Solution and Service
3.7 Date of Enter into Scoliosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Scoliosis Treatment Breakdown Data by Type
4.1 Global Scoliosis Treatment Historic Market Size by Type (2019-2024)
4.2 Global Scoliosis Treatment Forecasted Market Size by Type (2025-2030)
5 Scoliosis Treatment Breakdown Data by Application
5.1 Global Scoliosis Treatment Historic Market Size by Application (2019-2024)
5.2 Global Scoliosis Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Scoliosis Treatment Market Size (2019-2030)
6.2 North America Scoliosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Scoliosis Treatment Market Size by Country (2019-2024)
6.4 North America Scoliosis Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Scoliosis Treatment Market Size (2019-2030)
7.2 Europe Scoliosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Scoliosis Treatment Market Size by Country (2019-2024)
7.4 Europe Scoliosis Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Scoliosis Treatment Market Size (2019-2030)
8.2 Asia-Pacific Scoliosis Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Scoliosis Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Scoliosis Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Scoliosis Treatment Market Size (2019-2030)
9.2 Latin America Scoliosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Scoliosis Treatment Market Size by Country (2019-2024)
9.4 Latin America Scoliosis Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Scoliosis Treatment Market Size (2019-2030)
10.2 Middle East & Africa Scoliosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Scoliosis Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Scoliosis Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boston Orthotics & Prosthetics
11.1.1 Boston Orthotics & Prosthetics Company Detail
11.1.2 Boston Orthotics & Prosthetics Business Overview
11.1.3 Boston Orthotics & Prosthetics Scoliosis Treatment Introduction
11.1.4 Boston Orthotics & Prosthetics Revenue in Scoliosis Treatment Business (2019-2024)
11.1.5 Boston Orthotics & Prosthetics Recent Development
11.2 Chaneco
11.2.1 Chaneco Company Detail
11.2.2 Chaneco Business Overview
11.2.3 Chaneco Scoliosis Treatment Introduction
11.2.4 Chaneco Revenue in Scoliosis Treatment Business (2019-2024)
11.2.5 Chaneco Recent Development
11.3 Charleston Bending Brace
11.3.1 Charleston Bending Brace Company Detail
11.3.2 Charleston Bending Brace Business Overview
11.3.3 Charleston Bending Brace Scoliosis Treatment Introduction
11.3.4 Charleston Bending Brace Revenue in Scoliosis Treatment Business (2019-2024)
11.3.5 Charleston Bending Brace Recent Development
11.4 Orthotech
11.4.1 Orthotech Company Detail
11.4.2 Orthotech Business Overview
11.4.3 Orthotech Scoliosis Treatment Introduction
11.4.4 Orthotech Revenue in Scoliosis Treatment Business (2019-2024)
11.4.5 Orthotech Recent Development
11.5 Trulife
11.5.1 Trulife Company Detail
11.5.2 Trulife Business Overview
11.5.3 Trulife Scoliosis Treatment Introduction
11.5.4 Trulife Revenue in Scoliosis Treatment Business (2019-2024)
11.5.5 Trulife Recent Development
11.6 Össur
11.6.1 Össur Company Detail
11.6.2 Össur Business Overview
11.6.3 Össur Scoliosis Treatment Introduction
11.6.4 Össur Revenue in Scoliosis Treatment Business (2019-2024)
11.6.5 Össur Recent Development
11.7 DJO
11.7.1 DJO Company Detail
11.7.2 DJO Business Overview
11.7.3 DJO Scoliosis Treatment Introduction
11.7.4 DJO Revenue in Scoliosis Treatment Business (2019-2024)
11.7.5 DJO Recent Development
11.8 Wilmington Orthotics & Prosthetics, Inc.
11.8.1 Wilmington Orthotics & Prosthetics, Inc. Company Detail
11.8.2 Wilmington Orthotics & Prosthetics, Inc. Business Overview
11.8.3 Wilmington Orthotics & Prosthetics, Inc. Scoliosis Treatment Introduction
11.8.4 Wilmington Orthotics & Prosthetics, Inc. Revenue in Scoliosis Treatment Business (2019-2024)
11.8.5 Wilmington Orthotics & Prosthetics, Inc. Recent Development
11.9 Lawall Prosthetics and Orthotics
11.9.1 Lawall Prosthetics and Orthotics Company Detail
11.9.2 Lawall Prosthetics and Orthotics Business Overview
11.9.3 Lawall Prosthetics and Orthotics Scoliosis Treatment Introduction
11.9.4 Lawall Prosthetics and Orthotics Revenue in Scoliosis Treatment Business (2019-2024)
11.9.5 Lawall Prosthetics and Orthotics Recent Development
11.10 Horton's Orthotics & Prosthetics
11.10.1 Horton's Orthotics & Prosthetics Company Detail
11.10.2 Horton's Orthotics & Prosthetics Business Overview
11.10.3 Horton's Orthotics & Prosthetics Scoliosis Treatment Introduction
11.10.4 Horton's Orthotics & Prosthetics Revenue in Scoliosis Treatment Business (2019-2024)
11.10.5 Horton's Orthotics & Prosthetics Recent Development
11.11 Aspen Medical Products
11.11.1 Aspen Medical Products Company Detail
11.11.2 Aspen Medical Products Business Overview
11.11.3 Aspen Medical Products Scoliosis Treatment Introduction
11.11.4 Aspen Medical Products Revenue in Scoliosis Treatment Business (2019-2024)
11.11.5 Aspen Medical Products Recent Development
11.12 UNYQ
11.12.1 UNYQ Company Detail
11.12.2 UNYQ Business Overview
11.12.3 UNYQ Scoliosis Treatment Introduction
11.12.4 UNYQ Revenue in Scoliosis Treatment Business (2019-2024)
11.12.5 UNYQ Recent Development
11.13 C H Martin Company
11.13.1 C H Martin Company Company Detail
11.13.2 C H Martin Company Business Overview
11.13.3 C H Martin Company Scoliosis Treatment Introduction
11.13.4 C H Martin Company Revenue in Scoliosis Treatment Business (2019-2024)
11.13.5 C H Martin Company Recent Development
11.14 Optec USA, Inc.
11.14.1 Optec USA, Inc. Company Detail
11.14.2 Optec USA, Inc. Business Overview
11.14.3 Optec USA, Inc. Scoliosis Treatment Introduction
11.14.4 Optec USA, Inc. Revenue in Scoliosis Treatment Business (2019-2024)
11.14.5 Optec USA, Inc. Recent Development
11.15 Spinal Technology, Inc.
11.15.1 Spinal Technology, Inc. Company Detail
11.15.2 Spinal Technology, Inc. Business Overview
11.15.3 Spinal Technology, Inc. Scoliosis Treatment Introduction
11.15.4 Spinal Technology, Inc. Revenue in Scoliosis Treatment Business (2019-2024)
11.15.5 Spinal Technology, Inc. Recent Development
11.16 Zimmer Biomet Holdings Inc.
11.16.1 Zimmer Biomet Holdings Inc. Company Detail
11.16.2 Zimmer Biomet Holdings Inc. Business Overview
11.16.3 Zimmer Biomet Holdings Inc. Scoliosis Treatment Introduction
11.16.4 Zimmer Biomet Holdings Inc. Revenue in Scoliosis Treatment Business (2019-2024)
11.16.5 Zimmer Biomet Holdings Inc. Recent Development
11.17 NuVasive
11.17.1 NuVasive Company Detail
11.17.2 NuVasive Business Overview
11.17.3 NuVasive Scoliosis Treatment Introduction
11.17.4 NuVasive Revenue in Scoliosis Treatment Business (2019-2024)
11.17.5 NuVasive Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research